Patent Number: 8,821,892

Title: Yeast-based therapeutic for chronic hepatitis C infection

Abstract: Disclosed are compositions, including vaccines, and methods for vaccinating an animal against hepatitis C virus (HCV) and for treating or preventing hepatitis C viral infection in an animal. The invention includes a variety of novel HCV fusion proteins that can be used directly as a vaccine or in conjunction with a yeast-based vaccine vehicle to elicit an immune response against HCV in an animal. The invention also includes the use of the HCV fusion gene and protein described herein in any diagnostic or therapeutic protocol for the detection and/or treatment or prevention of HCV infection.

Inventors: Duke; Richard C. (Denver, CO), Franzusoff; Alex (Nahant, MA), Haller; Aurelia (Boulder, CO), King; Thomas H. (Denver, CO)

Assignee: GlobeImmune, Inc.

International Classification: A61K 39/29 (20060101); A61K 39/00 (20060101); A61K 45/00 (20060101); C12N 1/00 (20060101); C12N 1/19 (20060101)

Expiration Date: 9/02/12018